The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Final analysis of phase II trial of regorafenib (REG) in refractory advanced biliary cancers (BC).
 
Dae Won Kim
No Relationships to Disclose
 
Hanna Kelly Sanoff
Research Funding - Bayer (Inst); Merck (Inst)
 
Andrew Stewart Poklepovic
No Relationships to Disclose
 
Fatima Tariq
No Relationships to Disclose
 
Andrew B. Nixon
Consulting or Advisory Role - Kanghong Pharma; Lilly; Pfizer
Research Funding - Acceleron Pharma; Amgen; AstraZeneca/MedImmune; Eureka Therapeutics; Genentech/Roche; Leadiant Biosciences; medpacto; Novartis; Seagen; TRACON Pharma
Patents, Royalties, Other Intellectual Property - Patent (Inst); Patent Pending (Inst)
Travel, Accommodations, Expenses - TRACON Pharma
 
Yingmiao Liu
No Relationships to Disclose
 
Richard D. Kim
Honoraria - Bristol-Myers Squibb
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Genentech; Lilly
Speakers' Bureau - Lilly; Taiho Pharmaceutical
Research Funding - Bayer; Eisai; Novartis